CancerIQ’s Post

Our healthcare system in the United States is broken in a lot of ways. Getting a cancer diagnosis shouldn't mean that you go into debt for the rest of your life. When you're trying to fight cancer, the last thing you should be worried about is whether or not you can afford it. This is why health equity is so important to me. When we tackle inequities, we see better patient outcomes. “Cancer survival rates over recent years have shown improvement across races and ethnicities, so by acknowledging and addressing barriers to care, further improvements toward equitable access, treatment, and outcomes can be realized for all,” says Lori Pierce. If we want to see even more positive change when it comes to cancer care, we have to see an embrace of health equity throughout all medical care. It's also important to note that we can't only focus on increasing accessibility to care... we have to also make sure that care is unbiased and that healthcare providers are aware of inequities that affect medical care overall. #CancerCare #HealthEquity #Healthcare #CancerPreventionMonth

Osara Health partners with Allstate to offer members cancer care support - MobiHealthNews #OsaraHealthPartnershipwithAllstate #CancerCareSupport Osara Health has recently announced a partnership with Allstate to provide cancer care support to its members. This collaboration aims to offer comprehensive resources and assistance to individuals facing a cancer diagnosis. #Benefits of Partnership The partnership between Osara Health and Allstate will provide members with access to a wide range of support services, including financial assistance, care coordination, and emotional support. #Integrated Care Model Osara Health and Allstate will work together to develop an integrated care model that focuses on personalized care plans and holistic support for cancer patients. This approach aims to improve outcomes and enhance the overall patient experience. #Technology Integration The partnership will leverage innovative technology solutions ai.mediformatica.com #cancer #health #behavior #cancercare #change #behaviorchange #benefits #acce #core #evidence #healthoutcomes #holisticcare #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4343erm)

Cancer recently emerged as the top healthcare cost for employers. As employers look to manage this growing healthcare threat, many may consider adding a new point solution. Some employers are already offering an integrated solution that offers employees the cancer support they need. During a recent From Day One webinar titled “Overcoming Cancer Challenges: Is Your Existing Solution the Answer?” team members from Accolade, Inc. discussed how a personalized approach to healthcare can offer cancer prevention and support that improves care, cost, and outcomes. Thank you to speakers April Ries, Erin Hirshorn, and moderator Morgan McHugh. #FD1Conference #FD1Sponsor #FD1Editorial

The initiative aims to improve health outcomes in medically underrepresented communities across the United States by enhancing awareness of and access to cancer screenings, clinical trial opportunities, and patient support and comprehensive navigation. https://lnkd.in/eyUyzXiz

For employers and labor unions, who provide healthcare coverage for nearly half of all Americans, supporting the entire cancer care journey is no longer just nice to have—it’s a necessity. That’s why we’re expanding to an end-to-end comprehensive cancer solution, in partnership with the American Cancer Society. To impact outcomes and cost, employers should look to take a two-pronged approach to cancer management: 1⃣ Help employees catch cancer earlier through evidence-based and covered interventions. 2⃣ Navigate employees through treatment with comprehensive care from diagnosis to remission. Read more in our recent blog ➡️ https://lnkd.in/gyAKheUm

This is a needed trend which I know is coming. Obviously this will have nuanced hurdles as hospitals will be hesitant to be responsible for patients outside of their walls and even moreso to give up said incentives to keep patients inside their walls (virtual or otherwise.). We will be eager to hear more about the planned strategies and technologies available to decide which patients and which treatment te are most suitable for this paradigm shift. Injectables and at home supportive infusions are obviously a pathway. Supportive care teams to help assess and guide need for urgent care or assessment will be crucial. Mobile services and clinical availability will likely round out the delivery and peri-therapeutic events and issues. And of course clinician buy in and guidance will be an evolution. Ultimately the time is ripe and right for this transition. The politics and delegation of responsibility will need creative and autonomous clinicians and systems willing to improve quality, increase efficiency, and reduce costs. The incentive model will need to re-evaluate where we are and seek to remove historic barriers to allow the logistics to flourish as a priority.

Learn more about the current status of home-based cancer care, including the possibilities and challenges that exist in delivering cancer care at home and focusing on true patient centricity. Register today to improve your practical knowledge about how to effectively implement cancer care at home so it best serves the patients. #cancercareathome #clinicalpathwayscongress #cancercarebusinessexchange #CPC_CBEx

🎉 Wrapping up November! 🎊 Hey LinkedIn folks, As we say goodbye to November today, it's a moment to look back on 2023's journey. Tomorrow marks December, the final stretch of the year. Taking a second to highlight the impact of integrated care systems. This year showed us how these systems, bringing together different healthcare elements, can make a real difference. They break down old walls, making sure patient care is smooth and centered on their needs. Entering December, let's keep pushing for integrated care. It's more than a trend; it's a change that can shake up healthcare and make life better for many. Cheers to the last month of 2023, time for thinking, being thankful, and keeping the healthcare evolution going! #December1st #IntegratedCare #HealthcareJourney #YearEndVibes App for cancer patients launches in Tameside and Glossop Cancer patients in Tameside and Glossop now have a convenient way to receive personalized advice and support, thanks to a recently launched app. Introduced in September 2023, the Tameside and Glossop NHS ICFT’s Patient Portal serves as a comprehensive hub for cancer-related health and wellbeing information. Within the app, patients can explore a range of information and guides and engage with Cancer Care Coordinators to discuss their care. This digital tool empowers the Cancer team to offer tailored support as patients navigate through different stages of treatment. It's important to note that this digital option supplements the existing avenues for patient support, which include telephone, email, and in-person interactions. Tameside and Glossop Integrated Care NHS FT NHS Professionals NHS in UK NHS England https://lnkd.in/dPg6y9Ni #CancerSupport #PatientCare #HealthTech #DigitalHealth #CancerAwareness #HealthcareInnovation #TechForGood #PatientEmpowerment #TamesideGlossopNHS #PersonalizedHealthcare #DigitalSupport #CancerJourney #HealthInformation #PatientPortal #TechInHealthcare #InnovativeHealthcare #CancerCareCoordination #DigitalWellbeing #HealthApp #EmpoweringPatients #SupportInnovation

Over the past decade, I've focused deeply into the implications of value-based care and quality measurement for the pharmaceutical industry, particularly in terms of its strategies for market access, evidence generation, government policy, health equity, and patient advocacy. Simultaneously, I've maintained a strong interest in addressing fundamental flaws within our healthcare system, aiming to instigate positive systemic change.   With a scientific background and extensive involvement in clinical trials throughout the early years of my career, I've had the opportunity to focus on exploring more recently how our healthcare data infrastructure can evolve to align with the Quintuple Aim objectives. Specifically, I'm passionate about effecting change to improve patient outcomes, enhance patient and provider experiences, reduce the total cost of care, and advance health equity.   I'm excited to currently be involved in work that contributes to the establishment of a foundation for data interoperability in cancer care. Collaborators across health care, public health, industry, and technology sectors are working together on initiatives like the United States Core Data for Interoperability Plus Cancer (USCDI+ Cancer) to support whole-person, precision care incentivized by value-based care and quality measurement, as is talked about in the article below. This work aims to build infrastructure to facilitate meaningful data sharing across clinical care, public health, clinical research, and other systems involved in patient care and services.   In my current role as a Senior Consultant (ONC Contractor) through Next Level Health Innovations, LLC, I'm actively involved in implementing and advancing USCDI+ Cancer. Our near-term goal is to ensure that real-world use cases, such as the Enhanced Oncology Model, cancer registries, immune-mediated adverse events, and clinical trial matching, benefit from enhanced data interoperability. Through this work, we aim to foster a more cohesive and effective healthcare ecosystem. It’s truly fulfilling to contribute to this work, and I look forward to continuing to partner with many others to make a meaningful impact in this space. #valuebasedcare #publichealth #clinicalresearch #wholepersoncare #datainteroperability #cancercare #cancerresearch #fhir #USCDI Office of the National Coordinator for Health Information Technology (ONC) National Cancer Institute (NCI) The National Institutes of Health Centers for Disease Control and Prevention NAACCR, Inc.

The Biden Cancer Moonshot and associated public-private partnership, CancerX Moonshot are driving change and innovation across the cancer care ecosystem, including through improved electronic health records. We’re proud to be committed to adopting the core Centers for Medicare & Medicaid Services #EnhancingOncologyModel data elements that cover vital information about a person’s treatment history, test results, and disease status in OncoEMR. For more on what this means for people with cancer, read: https://lnkd.in/gx7q_YFS